Prevent Cancer Dialogue

The Prevent Cancer Dialogue brings together a diverse group of partners to discuss the latest advances in research, policy, practice and programs in cancer prevention and early detection. Experts in the field give timely and enlightening presentations on trending topics with opportunities for discussion and peer-to-peer conversations among participants. Participants take Dialogue learnings back to their communities and workplaces to enhance or expand their work.

The 2026 Prevent Cancer Dialogue: Community Impact Through Collaboration was held in person May 7-8, 2026, at the Renaissance Arlington Capital View Hotel in Arlington, Virginia.

Topics included:

• Current trends and looking ahead at prevention: discussions covered multiple topics from dietary recommendations to genomics and precision prevention
• Innovative successes at the community level
• Harnessing AI tools to address patient populations and gaps in care, and patient perceptions as this technology progresses
• Expert-led workshopping sessions on motivational interviewing, health misinformation & mythbusting, grant writing and self care: resilience in patient-facing roles
• Landscape and direction of early detection, including interventions such as multi-cancer detection, molecular residual disease and biomarkers
• Current advocacy and policy issues
• State of the science overviews in breast, lung, colorectal, HPV-associated cancers, and hepatitis B, C and liver cancer

View the Agenda

Explore the Prevent Cancer Dialogue virtual series

“I have found the session to be very helpful! And easy to join with a very busy schedule. The speakers have always been high quality as well.”

“I thought this presentation was great. The speakers were extremely knowledgeable and I learned so much about a topic I wasn’t very familiar with prior to watching this presentation.”

These 90-minute webinars feature presentations from experts in the field and moderated discussions with the audience.

Past topics include:

• Updates on young-onset cancers: What to know and public health implications

• Diversifying clinical trial participation: Pathways from screenings to trials

• Molecular residual disease: Exploring the impact of cancer early detection and personalized care

Register to view these recordings and more, free of charge, on the Dialogue eLearning platform today!

CLICK TO ACCESS WEBINAR RECORDINGS

Special thank you to the 2026 Dialogue supporters!

If your organization  would like to support the 2026 Prevent Cancer Dialogue, or for more information on how you can become a corporate partner of the Prevent Cancer Foundation, please contact Jennifer Niyangoda at 703-837-3684 or Jennifer.Niyangoda@preventcancer.org.

Dialogue highlight